Companies Dominating the Allergy Immunotherapy Landscape
-
The competitive landscape of the allergy immunotherapy market is inspiring the global players to expand their market share. Companies involved in the emerging markets of the U.S., such as Thermo Fisher Scientific and Regeneron Pharmaceuticals, are leveraging advanced injectable treatments. While other key players, including ALK-Abelló and Stallergenes Greer, are dominating the industry with sublingual and subcutaneous treatments. This is further dragging the interest in conducting research activities and bringing innovation in the field, especially for biologics and immunotherapies targeting severe allergic reactions.
Company Name
Country of Origin
Industry Focus
ALK-Abelló A/S
Denmark
SLIT/SCIT therapies for pollen, mite, and food allergies
Stallergenes Greer
Switzerland
Global SLIT and SCIT manufacturer, broad allergen portfolio
Allergy Therapeutics
UK
SCIT and peptide-based immunotherapy
HAL Allergy B.V.
Netherlands
SCIT/SLIT for airborne allergens and insect venoms
DBV Technologies
France
Epicutaneous immunotherapy (EPIT) focuses on food allergy
Jubilant HollisterStier
USA/India
Contract manufacturing of allergy immunotherapy products
Circassia Group
UK
Biopharmaceuticals with an allergy focus (divested in recent years)
Zydus Lifesciences
India
Allergy vaccines and biologics, expanding the immunotherapy line
Biogenics Research & Training
India
Focused on allergy vaccine development and testing
Inmunotek S.L.
Spain
Manufacturer of allergen vaccines and diagnostics
BioPharma Laboratories
Australia
Allergy testing and immunotherapy production
Curalogic A/S (defunct)
Denmark
Developed allergy vaccines (merged/divested)
Alletess Medical Laboratory
USA
Allergy testing and personalized immunotherapy services
Medinova Laboratories
Malaysia
Local manufacturer of allergy treatment solutions
Hanmi Pharmaceutical
South Korea
R&D focuses on biologics, including allergy-related therapeutics
Protherics (BTG plc)
UK
Allergy and venom immunotherapy (now part of BTG)
Immunomic Therapeutics
USA
DNA-based immunotherapy platforms for allergies
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Below are the areas covered for each company under the top 15 global manufacturers: